273 related articles for article (PubMed ID: 22366809)
1. Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease.
Hueppelshaeuser R; von Unruh GE; Habbig S; Beck BB; Buderus S; Hesse A; Hoppe B
Pediatr Nephrol; 2012 Jul; 27(7):1103-9. PubMed ID: 22366809
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
Siener R; Ernsten C; Speller J; Scheurlen C; Sauerbruch T; Hesse A
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257157
[TBL] [Abstract][Full Text] [Related]
3. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.
Geraghty R; Wood K; Sayer JA
Urolithiasis; 2020 Oct; 48(5):377-384. PubMed ID: 32719990
[TBL] [Abstract][Full Text] [Related]
4. Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.
Sikora P; Beck B; Zajaczkowska M; Hoppe B
Urol Res; 2009 Apr; 37(2):101-5. PubMed ID: 19183975
[TBL] [Abstract][Full Text] [Related]
5. [Secondary oxalosis following small bowel resection with kidney insufficiency and oxalate vasculopathy].
Kiss D; Meier R; Gyr K; Wegmann W
Schweiz Med Wochenschr; 1992 May; 122(22):854-7. PubMed ID: 1604291
[TBL] [Abstract][Full Text] [Related]
6. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.
Ellis SR; Hulton SA; McKiernan PJ; de Ville de Goyet J; Kelly DA
Nephrol Dial Transplant; 2001 Feb; 16(2):348-54. PubMed ID: 11158411
[TBL] [Abstract][Full Text] [Related]
7. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population.
Bianchi L; Gaiani F; Bizzarri B; Minelli R; Cortegoso Valdivia P; Leandro G; Di Mario F; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):76-80. PubMed ID: 30561398
[TBL] [Abstract][Full Text] [Related]
8. [13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria.
Sikora P; von Unruh GE; Beck B; Feldkötter M; Zajaczkowska M; Hesse A; Hoppe B
Kidney Int; 2008 May; 73(10):1181-6. PubMed ID: 18337715
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of anemia after kidney transplantation in severe secondary oxalosis.
Bernhardt WM; Schefold JC; Weichert W; Rudolph B; Frei U; Groneberg DA; Schindler R
Clin Nephrol; 2006 Mar; 65(3):216-21. PubMed ID: 16550754
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
Marangella M; Vitale C; Petrarulo M; Linari F
Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
[TBL] [Abstract][Full Text] [Related]
11. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
12. Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria.
Cao Y; Liu W; Hui L; Zhao J; Yang X; Wang Y; Niu H
Urolithiasis; 2016 Oct; 44(5):389-97. PubMed ID: 27040948
[TBL] [Abstract][Full Text] [Related]
13. A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys.
Bodakhe KS; Namdeo KP; Patra KC; Machwal L; Pareta SK
Chin J Nat Med; 2013 Sep; 11(5):466-71. PubMed ID: 24359768
[TBL] [Abstract][Full Text] [Related]
14. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Milliner D; Hoppe B; Groothoff J
Urolithiasis; 2018 Aug; 46(4):313-323. PubMed ID: 28718073
[TBL] [Abstract][Full Text] [Related]
15. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Hoppe B; Niaudet P; Salomon R; Harambat J; Hulton SA; Van't Hoff W; Moochhala SH; Deschênes G; Lindner E; Sjögren A; Cochat P
Pediatr Nephrol; 2017 May; 32(5):781-790. PubMed ID: 27924398
[TBL] [Abstract][Full Text] [Related]
16. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
Gnanandarajah JS; Abrahante JE; Lulich JP; Murtaugh MP
Urol Res; 2012 Oct; 40(5):467-73. PubMed ID: 22223029
[TBL] [Abstract][Full Text] [Related]
17. Failure of allopurinol to modify urinary composition in enteric hyperoxaluria.
D'Cruz DP; Gertner DJ; Kasidas GP; Rampton DS; Rose GA; Samuell CT
Br J Urol; 1989 Sep; 64(3):231-4. PubMed ID: 2804558
[TBL] [Abstract][Full Text] [Related]
18. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
[TBL] [Abstract][Full Text] [Related]
19. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Bone histopathology and oxalate body content.
Toussaint C; Vienne A; De Pauw L; Gelin M; Janssen F; Hall M; Schurmans T; Pasteels JL
Transplantation; 1995 Jun; 59(12):1700-4. PubMed ID: 7604440
[TBL] [Abstract][Full Text] [Related]
20. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F
Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
